Skip to main content
Livermore
Livermore
ZHEN

Birchview Capital, LP

SEC CIK
0001618205
Latest filing
Aug 14, 2026

ACAD holding history

Acadia Pharmaceuticals Inc in every 13F filed by Birchview Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACAD overviewAll 13F holders of ACADFull Q2 2026 holdings

Shares (Q2 2026)
171,000
Value
$4.33M
% of portfolio
2.0%
Quarters held
22
Since Q1 2021
Holdings of ACAD by Birchview Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026171,000$4.33M2.0%00.0%UnchangedHolders
Q1 2026171,000$3.81M2.2%00.0%UnchangedHolders
Q4 2025171,000$4.57M2.7%00.0%UnchangedHolders
Q3 2025171,000$3.65M2.8%−16,800−8.9%ReducedHolders
Q2 2025187,800$4.05M4.0%−75,600−28.7%ReducedHolders
Q1 2025263,400$4.38M3.8%−75,000−22.2%ReducedHolders
Q4 2024338,400$6.21M5.1%−62,000−15.5%ReducedHolders
Q3 2024400,400$6.16M5.3%+150,000+59.9%AddedHolders
Q2 2024250,400$4.07M3.8%00.0%UnchangedHolders
Q1 2024250,400$4.63M3.8%+10,000+4.2%AddedHolders
Q4 2023240,400$7.53M5.9%00.0%UnchangedHolders
Q3 2023240,400$5.01M4.3%−9,000−3.6%ReducedHolders
Q2 2023249,400$5.97M4.5%00.0%UnchangedHolders
Q1 2023249,400$4.69M3.7%00.0%UnchangedHolders
Q4 2022249,400$3.97M2.8%00.0%UnchangedHolders
Q3 2022249,400$4.08M2.9%00.0%UnchangedHolders
Q2 2022249,400$3.51M2.6%+50,000+25.1%AddedHolders
Q1 2022199,400$4.83M3.5%00.0%UnchangedHolders
Q4 2021199,400$4.65M3.0%00.0%UnchangedHolders
Q3 2021199,400$3.31M2.3%00.0%UnchangedHolders
Q2 2021199,400$4.86M2.9%+22,400+12.7%AddedHolders
Q1 2021177,000$4.57M2.7%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.